Justin Renz
Director of Finance/CFO at ARDELYX, INC.
Net worth: 2 M $ as of 2024-04-29
Network origin in Justin Renz first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA
28
| Extinct | Pharmaceuticals: Other | 28 |
| Public Company | Pharmaceuticals: Major | 19 | |
| Public Company | Pharmaceuticals: Major | 10 | |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA
9
| Subsidiary | Pharmaceuticals: Major | 9 |
| Subsidiary | Pharmaceuticals: Major | 9 | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Justin Renz via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Medical Specialties | Director/Board Member Chief Executive Officer General Counsel Sales & Marketing | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Director/Board Member Director/Board Member Corporate Officer/Principal | |
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Director/Board Member | |
| University of Pennsylvania | College/University | Masters Business Admin Graduate Degree Undergraduate Degree | |
| University of British Columbia | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Graduate Degree Undergraduate Degree Masters Business Admin | |
| Boston University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| Yale University | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
| PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal General Counsel | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Doctorate Degree Masters Business Admin | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| The University of Chicago | College/University | Corporate Officer/Principal Undergraduate Degree Masters Business Admin | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| SHIRE | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| EPIZYME, INC. | Biotechnology | Chairman Director/Board Member Chief Executive Officer | |
| McGill University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
IDRx, Inc.
 IDRx, Inc. Miscellaneous Commercial ServicesCommercial Services IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder Founder | |
| Simon Fraser University | College/University | Doctorate Degree Masters Business Admin | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Sales & Marketing Sales & Marketing | |
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The company is based in Cambridge, MA. | Miscellaneous Commercial Services | Chief Operating Officer President | |
EQRx International, Inc.
 EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder Founder | |
| EQRX, INC. | Pharmaceuticals: Major | Founder Founder | |
| University of Lund | College/University | Doctorate Degree Doctorate Degree | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Boston University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
| NOVAVAX, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ACCELERON PHARMA INC. | Biotechnology | Director/Board Member Director/Board Member | |
ZP Opco, Inc.
 ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| Stanford Law School | College/University | Graduate Degree Graduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Edimer Pharmaceuticals, Inc.
 Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edimer Pharmaceuticals, Inc. provides biopharmaceutical products for improving the health and quality of life of families living with XLHED. It has developed EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), which is a rare orphan disease that causes symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. The company was founded by Pascal Schneider and Olivier Gaide in 2009 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| KYMERA THERAPEUTICS, INC. | Biotechnology | Comptroller/Controller/Auditor General Counsel | |
| BG MEDICINE, INC. | Medical Specialties | Comptroller/Controller/Auditor Director of Finance/CFO | |
| Queen's University | College/University | Graduate Degree Masters Business Admin |
Statistics
International
| United States | 39 |
| Canada | 7 |
| United Kingdom | 3 |
| Israel | 2 |
| Ireland | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 15 |
| Commercial Services | 7 |
| Finance | 2 |
Operational
| Director/Board Member | 371 |
| Corporate Officer/Principal | 190 |
| Independent Dir/Board Member | 110 |
| Chairman | 63 |
| Undergraduate Degree | 62 |
Most connected contacts
| Insiders | |
|---|---|
| Anthony Evnin | 46 |
| David Mott | 45 |
| Mark Corrigan | 29 |
| Hartley Richardson | 26 |
| Robert M. Forrester | 25 |
| Alexis Borisy | 25 |
| James Edward Thomas | 25 |
| Michael Kauffman | 24 |
| Patrick J. Fortune | 24 |
| Sally Crawford | 22 |
| Bill Hunter | 22 |
| Jan Lundberg | 20 |
| Gordon Ringold | 20 |
| Mike Raab Raab | 20 |
| Mikael Dolsten | 19 |
- Stock Market
- Insiders
- Justin Renz
- Company connections
